Target intelligence / Profile preview

Beta-1,4-galactosyltransferase 4 (B4GALT4)

Target
B4GALT4
Molecular classification
Enzyme, Glycosyltransferase, Type II membrane protein
01

Overview

Beta-1,4-galactosyltransferase 4 (B4GALT4) is an enzyme encoded by the B4GALT4 gene, belonging to the glycosyltransferase family 7 (GT7), and is categorized as a type II membrane-bound glycoprotein localized mainly to the Golgi apparatus[1][2][3]. It catalyzes the transfer of galactose from UDP-galactose to terminal N-acetylglucosamine, glucose, or xylose residues in a beta-1,4 linkage, playing a specific role in the biosynthesis of glycoproteins, glycolipids (notably neolacto-series glycosphingolipids), and keratan sulfate[1][2][3]. The enzyme is crucial for forming N- and O-linked keratan sulfate proteoglycans and participates in the construction and elongation of mono- and disulfated disaccharide units in keratan sulfate, working cooperatively with other glycosyltransferases and sulfotransferases[2]. Loss or dysfunction of B4GALT4 leads to profound reduction in keratan sulfate synthesis and is associated with congenital disorders of glycosylation and spondylodysplastic Ehlers-Danlos syndrome types[1][2]. B4GALT4 is additionally characterized by essential N-glycosylation sites that determine its Golgi localization, stability, and enzymatic activity[1].

Other names
B4GALT4Beta-1,4-GalTase 4Beta4Gal-T4beta4Gal-T4beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferaselactotriaosylceramide beta-1,4-galactosyltransferaseN-acetyllactosamine synthaseNal synthaseUDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4UNQ552/PRO1109
02

Biological functions

Glycoprotein glycosylationGlycolipid biosynthesisSynthesis of keratan sulfateSynthesis of neolacto-series glycosphingolipidsN-acetyllactosamine (LacNac) synthesis
03

Disease associations

Congenital disorder of glycosylationEhlers-Danlos syndrome (spondylodysplastic type 2)possibly other glycosylation-related disorders
04

Safety considerations

No major drug-related safety concerns reportedpotential disease involvement with glycosylation disorders may pose therapeutic challenges

Beyond the preview

Go deeper on Beta-1,4-galactosyltransferase 4 (B4GALT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,4-galactosyltransferase 4 (B4GALT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call